Skip to content

Effect of Beet Juice Supplementation on Vascular and Inspiratory Muscle Function

Effect of Beet Juice Supplementation on Vascular and Inspiratory Muscle Function

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04920799
Enrollment
24
Registered
2021-06-10
Start date
2021-11-12
Completion date
2026-05-30
Last updated
2025-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Brief summary

Older adults with coronary artery disease (CAD) have impaired vascular and inspiratory muscle function. The objective of this study is to examine the effect of beet juice supplementation on vascular and inspiratory muscle function in older adults with CAD.

Interventions

DIETARY_SUPPLEMENTNitrate rich beetroot juice

Participants will drink nitrate rich beetroot juice (2.4 floz ; Beet It Sport Nitrate 400 concentrated beetroot shot; James White Drink, ltd) twice daily for two weeks.

Participants will drink nitrate depleted beetroot juice (2.4 floz ; Beet It placebo concentrated beetroot shot; James White Drink, ltd) twice daily for two weeks.

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Adults with coronary artery disease (CAD) based on an angiogram \>50% stenosis in any major epicardial vessel or history of myocardial infarction or history of coronary revascularization. * Considered to have stable CAD on optimal medical therapy * 60 to 85 years of age * Men and women (women must be postmenopausal either natural or surgical) * Able to give consent

Exclusion criteria

* Ejection fraction \<50%, unstable angina, recent myocardial infarction within 6 months * Coronary revascularization, including percutaneous coronary intervention and coronary artery bypass graft or thoracic surgery within 6 months. * Stroke, obstructive pulmonary disease, hepatitis B, C, HIV, seizures, or other relevant on-going or recurrent illness * Individuals that have participated in respiratory training within the last 12 months or cardiac rehabilitation within the last 6 months * Uncontrolled hypertension * Use of tobacco products including smoking traditional or e-cigarettes * Use of hormone replacement therapy in women or men (e.g., estrogen, progesterone or testosterone) * Regular aerobic exercise training * Unwilling to stop using mouthwash at least 1 week before the start of the study and during study participation * Unwilling to remain weight stable during study participation

Design outcomes

Primary

MeasureTime frameDescription
Change in endothelial functionBaseline up to following 2 weeks of experimental conditionEndothelial function will be determined using brachial artery flow-mediated dilation via high resolution duplex ultrasonography. Reactive hyperemia will be produced by inflating a forearm cuff to \ 250 mmHg for 5 minutes followed by rapid deflation.
Change in inspiratory muscle functionBaseline up to following 2 weeks of experimental conditionInspiratory muscle function including strength, power and endurance will be assessed using the POWERbreathe KH2 device

Secondary

MeasureTime frameDescription
Change in microvascular functionBaseline up to following 2 weeks of experimental conditionMicrovascular function will be assessed using the forearm blood flow response to submaximal handgrip exercise. Brachial artery blood flow and diameter will be assessed using ultrasound.
Change in central arterial stiffnessBaseline up to following 2 weeks of experimental conditionThe SphygmoCor XCEL device will be used to measure carotid to femoral pulse wave velocity.
Change in central arterial hemodynamicsBaseline up to following 2 weeks of experimental conditionThe SphygmoCor XCEL device will be used to obtain central pulse wave analysis.
Change in functional capacityBaseline up to following 2 weeks of experimental conditionUsing the Duke Activity Status Index we will assess participants' ability to perform daily activities.

Countries

United States

Contacts

Primary ContactDemetra Christou, PhD
ddchristou@hhp.ufl.edu352-294-1746
Backup ContactStephanie Lapierre, MS
ICPL@hhp.ufl.edu

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026